title: [Mucinous carcinoma of the prostate: critical review of Elbadawi's criteria].
abstract: OBJECTIVE
  We present our experience on prostatic mucinous adenocarcinoma and at once we practice an actualization and a critical review of Elbadawi's criteria.
  
  
  METHODS
  After reviewing 206 prostatic carcinomas diagnosed in our hospital, we describe one case that fulfill criteria for being considered a prostatic mucinous adenocarcinoma. We also carry out a wide literature review trying to define anew the including criteria of this tumour by the light of modern knowledge and technology.
  
  
  CONCLUSIONS
  We think that for accepting a tumour as a prostatic mucinous adenocarcinoma, this have to fulfill the following criteria: 1. "More than 25% of a significative tumoral sample is mucinous pattern and present, single or clustered, tumour cells floating in immunohistochemically probed, acidic and neutral, mucin lakes". 2. "Tumour is Gleason 3-4 cribiform pattern with direct transition to colloid areas and usually coexist with classic adenocarcinoma but papillary growth patterns should be excluded. Tumour may contain a moderate proportion of signet-ring cells". 3. "Immunohistochemical staining for PSA have to be strongly positive in both, cribiform and mucinous, areas". 4. "Those PSA nonreactive, or only focally positive, mucinous adenocarcinomas, could be labeled as prostatic only when local or distant mucinous carcinomas are ruled out".
authors.affiliation: Servicio de Urología, Hospital Comarcal de Monforte de Lemos, Lugo.
authors.forename: A
authors.initials: A
authors.lastname: Sousa Escandón
authors.forename: M
authors.initials: M
authors.lastname: Argüelles Pintos
authors.forename: J
authors.initials: J
authors.lastname: Picallo Sánchez
authors.forename: L
authors.initials: L
authors.lastname: Mateo Cambón
authors.forename: C
authors.initials: C
authors.lastname: González Uribarri
authors.forename: M
authors.initials: M
authors.lastname: Rico Morales
mesh_terms: D002288:Adenocarcinoma, Mucinous / Q000473:pathology*; D000368:Aged; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*